Sign in

PTX on Australian Securities Exchange

Prescient Therapeutics

Drug company

Prescient Therapeutics (ASX: PTX) is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt.2 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

2014Founded1

Compare with another stock.

  • TickerPTX on Australian Securities Exchange1
  • Industrybiotechnology1
  • HeadquartersMelbourne1
  • Legal formpublic company1
  • LEI529900U1VPNYOW01NM373
  • StatusActive3
  • LEI statusIssued and current3
  • Registered addressSuite 2 Level 11, 385 Bourke Street, 3000 Melbourne, Australia3
  • Registered withThe Australian Securities and Investment Commission, 006 569 1063

See how the biggest companies compare on our leaderboards

Prescient Therapeutics (ASX: PTX) is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt.2

The story

Prescient Therapeutics Ltd (Prescient) was created in 2014 by bringing together two small molecule drug assets from separate US private companies (Pathway Oncology for PTX-100 and AKTivate Therapeutics for PTX-200) into the existing ASX-listed shell company Virax Holdings Ltd (Virax). Paul Hopper, an Australian bio-entrepreneur, looking to access public markets to help develop the PTX-100 & PTX-200 assets, helped coordinate sequential reverse takeovers wherein Virax first acquired Pathway Oncology (deal announced 17 March 2014, completed 30 May 2014) and then AKTivate Therapeutics (deal announced 17 October 2014, completed 11 December 2014). Virax then changed its name to Prescient Therapeutics in December 2014.

Prescient expanded its focus into cellular therapies in 2019 with the in-house development of cell therapy enhancement platform, CellPryme, and in May 2020 announced the development of its universal immune receptor platform OmniCAR from technologies developed at University of Pennsylvania (Penn) and Oxford University.

From Wikipedia’s article on Prescient Therapeutics, shared under CC BY-SA 4.0.4

Timeline

  1. 2014Founded Founded1
  2. Dec 19, 1986Went public Listed on Australian Securities Exchange1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4